{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T10:28:22Z","timestamp":1773311302147,"version":"3.50.1"},"reference-count":42,"publisher":"Elsevier BV","issue":"25","license":[{"start":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T00:00:00Z","timestamp":1527811200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"OUHSC College of Medicine Alumni"},{"name":"American Heart Association Scientist Development","award":["14SDG18700043"],"award-info":[{"award-number":["14SDG18700043"]}]},{"name":"Oklahoma Center for Advancement for Science and Technology","award":["HR13-003"],"award-info":[{"award-number":["HR13-003"]}]},{"name":"National Institute of General Medical Sciences of the National Institutes of Health","award":["P20GM103447"],"award-info":[{"award-number":["P20GM103447"]}]},{"DOI":"10.13039\/100001298","name":"Presbyterian Health Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001298","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100015308","name":"Stephenson Cancer Center","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100015308","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2018,6]]},"DOI":"10.1016\/j.vaccine.2018.05.011","type":"journal-article","created":{"date-parts":[[2018,5,5]],"date-time":"2018-05-05T21:22:53Z","timestamp":1525555373000},"page":"3694-3700","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["IL-22 deficiency increases CD4 T cell responses to mucosal immunization"],"prefix":"10.1016","volume":"36","author":[{"given":"Scott A.","family":"Budda","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lauren A.","family":"Zenewicz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2018.05.011_b0005","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1196\/annals.1309.005","article-title":"Compartmentalization of the mucosal immune responses to commensal intestinal bacteria","volume":"1029","author":"Macpherson","year":"2004","journal-title":"Ann New York Acad Sci"},{"key":"10.1016\/j.vaccine.2018.05.011_b0010","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1196\/annals.1309.002","article-title":"The anatomy of mucosal immune responses","volume":"1029","author":"Garside","year":"2004","journal-title":"Ann New York Acad Sci"},{"key":"10.1016\/j.vaccine.2018.05.011_b0015","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-0-387-09550-9_1","article-title":"Overview of gut immunology","volume":"635","author":"Mason","year":"2008","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/j.vaccine.2018.05.011_b0020","first-page":"1","article-title":"Mucosal vaccination\u2013an old but still vital strategy","volume":"58","author":"Dlugonska","year":"2012","journal-title":"Ann Parasitol"},{"key":"10.1016\/j.vaccine.2018.05.011_b0025","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1038\/nri1777","article-title":"Mucosal vaccines: the promise and the challenge","volume":"6","author":"Neutra","year":"2006","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.vaccine.2018.05.011_b0030","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1038\/nri3251","article-title":"Recent progress in mucosal vaccine development: potential and limitations","volume":"12","author":"Lycke","year":"2012","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.vaccine.2018.05.011_b0035","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1146\/annurev-immunol-032414-112123","article-title":"Interleukin-22: immunobiology and pathology","volume":"33","author":"Dudakov","year":"2015","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.vaccine.2018.05.011_b0040","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1038\/nrd4176","article-title":"Therapeutic opportunities of the IL-22-IL-22R1 system","volume":"13","author":"Sabat","year":"2014","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.vaccine.2018.05.011_b0045","doi-asserted-by":"crossref","first-page":"4602","DOI":"10.4049\/jimmunol.1401244","article-title":"IL-22 fate reporter reveals origin and control of IL-22 production in homeostasis and infection","volume":"193","author":"Ahlfors","year":"2014","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2018.05.011_b0050","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.immuni.2004.07.007","article-title":"IL-22 increases the innate immunity of tissues","volume":"21","author":"Wolk","year":"2004","journal-title":"Immunity"},{"key":"10.1016\/j.vaccine.2018.05.011_b0055","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1016\/j.immuni.2008.11.003","article-title":"Innate and adaptive interleukin-22 protects mice from inflammatory bowel disease","volume":"29","author":"Zenewicz","year":"2008","journal-title":"Immunity"},{"key":"10.1016\/j.vaccine.2018.05.011_b0060","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1084\/jem.20102149","article-title":"Memory\/effector (CD45RB(lo)) CD4 T cells are controlled directly by IL-10 and cause IL-22-dependent intestinal pathology","volume":"208","author":"Kamanaka","year":"2011","journal-title":"J Exp Med"},{"key":"10.1016\/j.vaccine.2018.05.011_b0065","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1038\/mi.2013.33","article-title":"IL-23R+ innate lymphoid cells induce colitis via interleukin-22-dependent mechanism","volume":"7","author":"Eken","year":"2014","journal-title":"Mucosal Immunol"},{"key":"10.1016\/j.vaccine.2018.05.011_b0070","first-page":"534","article-title":"IL-22 ameliorates intestinal inflammation in a mouse model of ulcerative colitis","volume":"118","author":"Sugimoto","year":"2008","journal-title":"J Clin Invest"},{"key":"10.1016\/j.vaccine.2018.05.011_b0075","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1084\/jem.20082683","article-title":"STAT3 links IL-22 signaling in intestinal epithelial cells to mucosal wound healing","volume":"206","author":"Pickert","year":"2009","journal-title":"J Exp Med"},{"key":"10.1016\/j.vaccine.2018.05.011_b0080","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1038\/nm1720","article-title":"Interleukin-22 mediates early host defense against attaching and effacing bacterial pathogens","volume":"14","author":"Zheng","year":"2008","journal-title":"Nat Med"},{"key":"10.1016\/j.vaccine.2018.05.011_b0085","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/j.chom.2009.03.011","article-title":"Lipocalin-2 resistance confers an advantage to Salmonella enterica serotype Typhimurium for growth and survival in the inflamed intestine","volume":"5","author":"Raffatellu","year":"2009","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.vaccine.2018.05.011_b0090","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1038\/nature11535","article-title":"IL-22BP is regulated by the inflammasome and modulates tumorigenesis in the intestine","volume":"491","author":"Huber","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.vaccine.2018.05.011_b0095","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.immuni.2012.05.028","article-title":"Interleukin-22 protects intestinal stem cells from immune-mediated tissue damage and regulates sensitivity to graft versus host disease","volume":"37","author":"Hanash","year":"2012","journal-title":"Immunity"},{"key":"10.1016\/j.vaccine.2018.05.011_b0100","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1097\/SHK.0b013e3182749f96","article-title":"Interleukin-22 modulates gut epithelial and immune barrier functions following acute alcohol exposure and burn injury","volume":"39","author":"Rendon","year":"2013","journal-title":"Shock"},{"key":"10.1016\/j.vaccine.2018.05.011_b0105","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/j.immuni.2007.07.023","article-title":"Interleukin-22 but not interleukin-17 provides protection to hepatocytes during acute liver inflammation","volume":"27","author":"Zenewicz","year":"2007","journal-title":"Immunity"},{"key":"10.1016\/j.vaccine.2018.05.011_b0110","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1046\/j.1440-1711.1998.00709.x","article-title":"Defective TCR expression in transgenic mice constructed using cDNA-based alpha- and beta-chain genes under the control of heterologous regulatory elements","volume":"76","author":"Barnden","year":"1998","journal-title":"Immunol Cell Biol"},{"key":"10.1016\/j.vaccine.2018.05.011_b0115","doi-asserted-by":"crossref","first-page":"5306","DOI":"10.4049\/jimmunol.1300016","article-title":"IL-22 deficiency alters colonic microbiota to be transmissible and colitogenic","volume":"190","author":"Zenewicz","year":"2013","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2018.05.011_b0120","doi-asserted-by":"crossref","first-page":"2725","DOI":"10.1074\/jbc.M007837200","article-title":"Identification of the functional interleukin-22 (IL-22) receptor complex: the IL-10R2 chain (IL-10Rbeta) is a common chain of both the IL-10 and IL-22 (IL-10-related T cell-derived inducible factor, IL-TIF) receptor complexes","volume":"276","author":"Kotenko","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1016\/j.vaccine.2018.05.011_b0125","first-page":"1","article-title":"Mucosal delivery routes for optimal immunization: targeting immunity to the right tissues","volume":"354","author":"Czerkinsky","year":"2012","journal-title":"Curr Top Microbiol Immunol"},{"key":"10.1016\/j.vaccine.2018.05.011_b0130","article-title":"The role of inflammasome-derived IL-1 in driving IL-17 responses","author":"Mills","year":"2012","journal-title":"J Leukocyte Biol"},{"key":"10.1016\/j.vaccine.2018.05.011_b0135","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1056\/NEJMra1204186","article-title":"Designing tomorrow's vaccines","volume":"368","author":"Nabel","year":"2013","journal-title":"New Engl J Med"},{"key":"10.1016\/j.vaccine.2018.05.011_b0140","doi-asserted-by":"crossref","first-page":"7090","DOI":"10.4049\/jimmunol.166.12.7090","article-title":"Cloning and characterization of IL-22 binding protein, a natural antagonist of IL-10-related T cell-derived inducible factor\/IL-22","volume":"166","author":"Dumoutier","year":"2001","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2018.05.011_b0145","doi-asserted-by":"crossref","first-page":"7096","DOI":"10.4049\/jimmunol.166.12.7096","article-title":"Identification, cloning, and characterization of a novel soluble receptor that binds IL-22 and neutralizes its activity","volume":"166","author":"Kotenko","year":"2001","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2018.05.011_b0150","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1128\/IAI.01564-06","article-title":"Inhibition of interleukin-22 attenuates bacterial load and organ failure during acute polymicrobial sepsis","volume":"75","author":"Weber","year":"2007","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2018.05.011_b0155","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1084\/jem.20091669","article-title":"Chronic mucocutaneous candidiasis in APECED or thymoma patients correlates with autoimmunity to Th17-associated cytokines","volume":"207","author":"Kisand","year":"2010","journal-title":"J Exp Med"},{"key":"10.1016\/j.vaccine.2018.05.011_b0160","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaad.2018.01.016","article-title":"Efficacy and safety of fezakinumab (an IL-22 monoclonal antibody) in adults with moderate-to-severe atopic dermatitis inadequately controlled by conventional treatments: a randomized, double-blind, phase 2a trial","author":"Guttman-Yassky","year":"2018","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.vaccine.2018.05.011_b0165","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1038\/ni.2025","article-title":"Border patrol: regulation of immunity, inflammation and tissue homeostasis at barrier surfaces by IL-22","volume":"12","author":"Sonnenberg","year":"2011","journal-title":"Nat Immunol"},{"key":"10.1016\/j.vaccine.2018.05.011_b0170","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.immuni.2014.12.028","article-title":"Antimicrobial defense of the intestine","volume":"42","author":"Mukherjee","year":"2015","journal-title":"Immunity"},{"key":"10.1016\/j.vaccine.2018.05.011_b0175","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1038\/nature16460","article-title":"Interleukin-22 promotes intestinal-stem-cell-mediated epithelial regeneration","volume":"528","author":"Lindemans","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.vaccine.2018.05.011_b0180","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1126\/science.1222551","article-title":"Innate lymphoid cells promote anatomical containment of lymphoid-resident commensal bacteria","volume":"336","author":"Sonnenberg","year":"2012","journal-title":"Science"},{"key":"10.1016\/j.vaccine.2018.05.011_b0185","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1016\/j.immuni.2014.09.010","article-title":"Interleukin-22 regulates the complement system to promote resistance against pathobionts after pathogen-induced intestinal damage","volume":"41","author":"Hasegawa","year":"2014","journal-title":"Immunity"},{"key":"10.1016\/j.vaccine.2018.05.011_b0190","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1038\/mi.2012.72","article-title":"A role for mucosal IL-22 production and Th22 cells in HIV-associated mucosal immunopathogenesis","volume":"5","author":"Kim","year":"2012","journal-title":"Mucosal Immunol"},{"key":"10.1016\/j.vaccine.2018.05.011_b0195","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1038\/nm1651","article-title":"Human TH17 lymphocytes promote blood-brain barrier disruption and central nervous system inflammation","volume":"13","author":"Kebir","year":"2007","journal-title":"Nat Med"},{"key":"10.1016\/j.vaccine.2018.05.011_b0200","doi-asserted-by":"crossref","first-page":"3316","DOI":"10.4049\/jimmunol.1700152","article-title":"IL-22 increases permeability of intestinal epithelial tight junctions by enhancing claudin-2 expression","volume":"199","author":"Wang","year":"2017","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2018.05.011_b0205","doi-asserted-by":"crossref","first-page":"28058","DOI":"10.1038\/srep28058","article-title":"IL-22 dampens the T cell response in experimental malaria","volume":"6","author":"Sellau","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.vaccine.2018.05.011_b0210","doi-asserted-by":"crossref","first-page":"586","DOI":"10.3390\/v3050586","article-title":"CD4+ T cell depletion in human immunodeficiency virus (HIV) infection: role of apoptosis","volume":"3","author":"Fevrier","year":"2011","journal-title":"Viruses"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X18306182?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X18306182?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,5,19]],"date-time":"2020-05-19T12:13:32Z","timestamp":1589890412000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X18306182"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6]]},"references-count":42,"journal-issue":{"issue":"25","published-print":{"date-parts":[[2018,6]]}},"alternative-id":["S0264410X18306182"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2018.05.011","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2018,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"IL-22 deficiency increases CD4 T cell responses to mucosal immunization","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2018.05.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}